Pfizer discards one weight loss medication in ethnicity to conceive Ozempic adversary
June 27, 2023: On Monday, Pfizer stated that it would quit producing its observed obesity and diabetes medication, lotiglipron, because ...
June 27, 2023: On Monday, Pfizer stated that it would quit producing its observed obesity and diabetes medication, lotiglipron, because ...
January 30, 2023: -On Thursday, the Food and Drug Administration's independent advisory committee recommended which replaces ...
March 2, 2022: According to a study published Monday, Pfizer and BioNTech's two-dose Covid vaccine provided very little protection ...
February 16, 2022: -On Monday, the Food and Drug Administration's plan to fast-track Pfizer's Covid vaccine ...
February 10, 2022: -Pfizer projects it will generate record-high revenue in 2022, saying Tuesday it expects to sell ...
Pfizer and BioNTech launched a clinical study to evaluate the safety and effectiveness that targets the Covid omicron variant